One-month TB prevention regimen just as effective as 9-month regimen

Date: 03/06/2018

Publication:

NAM AIDSMap

. . . Speaking at a press conference after the presentation, Professor Chaisson said “This 1HP regimen could dramatically alter the landscape for the prevention of TB in people with HIV. The likelihood of completing it is extremely high and the likelihood of it preventing TB is extremely high.”

“We think it is a large enough, clear enough result, that it can form the basis of new guidelines.” . . . 

Access Full Article

Clinical Trials

A5290, A Randomized, Phase 2b Study of a Double-Dose...

Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...

Read More

A5342: Evaluating the Safety, Tolerability, and Effect of a...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

Read More

A5345, Identification of Biomarkers to Predict Time to...

Brief Summary: The purpose of this study is to collect information about what happens when people pause, or temporarily stop...

Read More

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...

Read More

A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

Read More